Vanessa Roldán - Concepedia

Author

Vanessa Roldán

Also Known As

Francisco Marín, Gonzalez Roldan, Valeria Ivonne, Inmaculada Roldán, V ROLDAN, V Roldan, V Roldan Schilling, V Roldán, V Roldán Schilling, V Roldán-Schilling, V SCHILLING

439

Publications

12.2K

Citations

H-Index

143

Concepts

All Affiliations

Universidad de Murcia Hospital General Universitario Morales Meseguer Hospital General Universitario de Alicante Doctor Balmis Hospital Universitario Virgen de la Arrixaca Birmingham City Hospital

About

Vanessa Roldán is an author at Universidad de Murcia specializing in medicine, cardiovascular disease, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	58	5.1K
2	Public Health	27	40	4.3K
3	Health Sciences	3	3	111
4	Engineering	1	1	26
5	Natural Sciences	1	1	14

Vanessa Roldán

130

Publications

Citations

H-Index

Page 1

	Year	Citations
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation Jan Steffel, Peter Verhamme, Tatjana Potpara, European Heart Journal Vitamin K AntagonistsThrombosisHypertensionCardiovascular DiseaseAtherosclerosis	2018	2.1K
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation Jan Steffel, Rónán Collins, Matthias Antz, EP Europace	2021	1K
Statins and Postoperative Risk of Atrial Fibrillation Following Coronary Artery Bypass Grafting Domingo A. Pascual‐Figal, Vanessa Roldán, José María Arribas, The American Journal of Cardiology Cardiac AnaesthesiaCardiothoracic SurgeryCardiovascular DiseasePostoperative RiskMedicine	2005	214
Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS) Christian Sticherling, David H. Birnie, Giuseppe Boriani, EP Europace Adult Cardiac SurgeryCardiovascular PharmacologyPharmacotherapyThrombosisVenous Thrombosis	2015	196
Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy Vanessa Roldán, Hermógenes Fernández, Sergio Manzano‐Fernández, CHEST Journal ThrombosisAtria Bleeding ScoresCardiovascular DiseaseSerious BleedingPredictive Value	2012	195
The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation Vanessa Roldán, Sergio Manzano‐Fernández, Pilar Gallego, Journal of the American College of Cardiology ThrombosisCardiovascular DiseaseAnticoagulated PatientsAtherosclerosisMedicine	2013	187
Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation Pilar Gallego, Vanessa Roldán, Marta Romera, Thrombosis and Haemostasis	2013	187
Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation Pilar Gallego, Vanessa Roldán, José Miguel Torregrosa Diaz, Circulation Arrhythmia and Electrophysiology	2012	147
Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation Vanessa Roldán European Heart Journal	2003	136
Plasma von Willebrand Factor Levels Are an Independent Risk Factor for Adverse Events Including Mortality and Major Bleeding in Anticoagulated Atrial Fibrillation Patients Vanessa Roldán, Begoña Muiña, José Miguel Torregrosa Diaz, Journal of the American College of Cardiology ThrombosisVenous ThrombosisCardiovascular DiseaseHematologyMajor Bleeding	2011	130

Page 1